Showing results (221-230 of 244) with videos related to
Sort By:
Pageof 25
Surgery Today|May 10, 2002
Transanal repair of rectourethral fistula after a radical retropubic prostatectomy: report of a caseFumitake Hata, Takahiro Yasoshima, Shingo Kitagawa, et al.Respiratory Medicine Case Reports|April 4, 2022
Acute respiratory failure due to Aspergillus niger infection with acute fibrinous and organazing pneumonia: A case reportKen Okamura, Rintaro Noro, Kazue Fujita, et al.BMC Cancer|May 30, 2013
Activity of EGFR-tyrosine kinase and ALK inhibitors for EML4-ALK-rearranged non-small-cell lung cancer harbored coexisting EGFR mutationAkihiko Miyanaga, Kumi Shimizu, Rintaro Noro, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 18, 2022
A Randomized Comparison of Nivolumab versus Nivolumab + Docetaxel for Previously Treated Advanced or Recurrent ICI-Naïve Non-Small Cell Lung Cancer: TORG1630Yuri Taniguchi, Tsuneo Shimokawa, Yuichi Takiguchi, et al.JTO Clinical and Research Reports|May 6, 2024
Immunotherapy With Radiotherapy for Brain Metastases in Patients With NSCLC: NEJ060Takehiro Tozuka, Yuji Minegishi, Ou Yamaguchi, et al.Cancer Science|December 23, 2025
Perioperative Nivolumab in Resectable Non-Small Cell Lung Cancer: A Subanalysis of Japanese Patients From Checkmate 77TFumihiro Tanaka, Yasutaka Watanabe, Shunichi Sugawara, et al.Lung Cancer (Amsterdam, Netherlands)|December 31, 2023
Prognostic value of predominant subtype in pathological stage II-III lung adenocarcinoma with epidermal growth factor receptor mutationShingo Kitagawa, Yoshitaka Zenke, Tetsuro Taki, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 11, 2016
A Two-Gene Prognostic Classifier for Early-Stage Lung Squamous Cell Carcinoma in Multiple Large-Scale and Geographically Diverse CohortsRintaro Noro, Teruhide Ishigame, Naomi Walsh, et al.Cancer Science|November 30, 2021
Alpha-actinin-4 (ACTN4) gene amplification is a predictive biomarker for adjuvant chemotherapy with tegafur/uracil in stage I lung adenocarcinomasRintaro Noro, Kazufumi Honda, Kengo Nagashima, et al.Cancer Science|May 14, 2026
Atezolizumab + Chemotherapy in Older Patients With Lung Cancer in JapanJunichi Shimizu, Makoto Nishio, Kadoaki Ohashi, et al.Pageof 25